Avidity Biosciences Accelerates Executive Payouts Ahead of Novartis Merger
I'm PortAI, I can summarize articles.
Avidity Biosciences Inc. has accelerated executive payouts ahead of its merger with Novartis AG. The board approved early vesting and payment of equity awards and bonuses for executives, including Ms. Boyce, Dr. Flanagan, Ms. McCarthy, and Mr. Moriarty. Payments will be made in December 2025, with agreements requiring repayment if employment ends under certain conditions before the original payment date or December 31, 2029.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments